Skip to main content
Clinical Trials/ISRCTN10874601
ISRCTN10874601
Completed
未知

Acceptability and clinical trial feasibility evaluation of auditory rhythmical cueing to improve gait and physical activity in community dwelling stroke survivors

orthumbria Healthcare NHS Foundation Trust0 sites60 target enrollmentMarch 12, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Stroke
Sponsor
orthumbria Healthcare NHS Foundation Trust
Enrollment
60
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32467770/ protocol (added 01/06/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36371213/ (added 14/11/2022)

Registry
who.int
Start Date
March 12, 2018
End Date
June 30, 2020
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orthumbria Healthcare NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults (\= 18 years)
  • 2\. Diagnosed with any stroke subtype
  • 3\. Within 24 months of stroke onset
  • 4\. Able to mobilise independently \>10 metres with/without stick indoors but presenting with a gait\-related mobility impairment (e.g. gait asymmetry, reduced walking speed, reduced balance, reduced walking confidence based on clinical observation or patient subjective feedback) that would potentially benefit from this intervention
  • 5\. Community dwelling
  • 6\. Living within the community services catchment area of a participating study centre
  • 7\. Able to provide informed consent to participate in the study
  • 8\. Able to follow study treatment (i.e. does not have significant cognitive impairment or communication difficulties)

Exclusion Criteria

  • 1\. Currently undertaking active physiotherapy
  • 2\. Unable to follow programme due to significant cognitive impairment or communication difficulties
  • Marked expressive/receptive dysphasia
  • 3\. Diagnosis likely to interfere with adherence to treatment or predispose to falls e.g. uncorrected hearing problems, registered blind, severe visual/inattention problems as a result of stroke, upper limb impairment restricting use of cueing device and able to mobilise 10 metres but extremely slow gait speed limited intervention adherence
  • 4\. Other neurological or orthopaedic conditions affecting gait (e.g. Parkinson's Disease, Multiple Sclerosis, osteoarthritis, rheumatoid arthritis and back pain) and cardiopulmonary conditions limiting walking ability (e.g. chronic obstructive disorders, angina pectoris) and palliative treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials